Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover Page

v3.22.4
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Feb. 20, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-35756    
Entity Registrant Name NEOGENOMICS, INC.    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 74-2897368    
Entity Address, Address Line One 9490 NeoGenomics Way    
Entity Address, City or Town Fort Myers    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33912    
City Area Code (239)    
Local Phone Number 768-0600    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol NEO    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 755
Entity Common Stock, Shares Outstanding   127,457,980  
Documents Incorporated by Reference Portions of the registrant’s Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.    
Entity Central Index Key 0001077183    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false